Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model

41Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chronic chagasic cardiomyopathy, which is caused by the protozoan Trypanosoma cruzi, is a major cause of heart failure in Latin America. It is a disease for which effective treatment in its advanced clinical forms is lacking. We have previously shown that bone marrow mononuclear cell (BMC) transplantation is effective in reducing inflammation and fibrosis in the mouse model of Chagas disease. The present study used magnetic resonance imaging to assess changes in the cardiac morphology of infected mice after therapy with BMCs. Serial imaging of the BMC-treated mice revealed regression of the right ventricular dilatation typically observed in the chagasic mouse model. © 2008 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Goldenberg, R. C. S., Jelicks, L. A., Fortes, F. S. A., Weiss, L. M., Rocha, L. L., Zhao, D., … Tanowitz, H. B. (2008). Bone marrow cell therapy ameliorates and reverses chagasic cardiomyopathy in a mouse model. Journal of Infectious Diseases, 197(4), 544–547. https://doi.org/10.1086/526793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free